Saudi JournalSaudi Journal
  • Home
  • Saudi Arabia
  • Business
  • Life
  • Technology
  • English
  • العربية
  • Submit A Press Release
Business

Yango Group expands ‘Points’ loyalty program to Abu Dhabi with valuable rewards for rides

…

Business

SBC Summit Malta to Spotlight Next-Gen Tech Driving the Future of Sports Betting

…

Stitch raises $10 million seed to extend services to emerging markets

Qatar’s PayLater receives strategic investment from LuLu AI

Facebook Twitter Instagram Pinterest
Latest posts:
  • Yango Group expands ‘Points’ loyalty program to Abu Dhabi with valuable rewards for rides
  • SBC Summit Malta to Spotlight Next-Gen Tech Driving the Future of Sports Betting
  • Stitch raises $10 million seed to extend services to emerging markets
  • Qatar’s PayLater receives strategic investment from LuLu AI
  • Seven Tides appoints Minor Hotels to manage DUKES The Palm
  • PUMA MIDDLE EAST INTRODUCES THE MOSTRO SQUAD
  • CNTXT AI and Beam Partner to Tackle the Gulf’s $5.4 Billion AI Agent Opportunity
  • Gainz closes pre-seed round to expand SME lending solutions
Facebook Twitter Instagram Pinterest
Saudi JournalSaudi Journal
  • Home

    Yango Group expands ‘Points’ loyalty program to Abu Dhabi with valuable rewards for rides

    SBC Summit Malta to Spotlight Next-Gen Tech Driving the Future of Sports Betting

    Stitch raises $10 million seed to extend services to emerging markets

    Qatar’s PayLater receives strategic investment from LuLu AI

    Seven Tides appoints Minor Hotels to manage DUKES The Palm

  • Saudi Arabia
  • Business
  • Life
  • Technology
  • English
  • العربية
  • Submit A Press Release
Saudi JournalSaudi Journal
Home » Hikma continues strong strategic execution and reiterates guidance
Business

Hikma continues strong strategic execution and reiterates guidance

Facebook Twitter Pinterest LinkedIn WhatsApp
Share
Facebook Twitter LinkedIn Pinterest WhatsApp

London, United Kingdom: Hikma Pharmaceuticals PLC (Hikma, Group), the multinational pharmaceutical group, today provides an update on current trading.

Riad Mishlawi, Hikma’s CEO, said: “I am pleased with our progress this year and we remain on track to deliver another strong performance in 2024, in line with our current guidance.  All three businesses are contributing, with new launches across our markets and investment in our infrastructure giving us confidence for the future.  We have made excellent strategic progress in the period, having closed the Xellia acquisition and signed an important contract manufacturing agreement for our Generics business.”

Group

The Group is performing well and we continue to expect Group revenue to grow in the range of 6% to 8% and for core operating profit to be in the range of $700 million to $730 million in 2024, in line with our previously upgraded guidance.

Injectables

In our global Injectables business, growth has accelerated in the second half of the year, driven by the previously expected second half weighting of contract manufacturing in Europe. We are also benefitting from sustained good demand for our own products in Europe, including in our new markets. Our MENA Injectables business is performing well, supported by new launches.

In North America, there is good demand for our broad portfolio, and we have launched ten products in the year to date, with more expected towards the end of the year.  We closed the Xellia acquisition in September and expect a revenue contribution of around $20 million this year, in line with previously set-out expectations.  We are now working on integrating the business and upgrading the Bedford, Ohio manufacturing facility.

Excluding the Xellia acquisition, we continue to expect 2024 Injectables revenue to grow in the range of 6% and 8% and for core operating margin to be between 36% and 37%.

Branded

Our Branded business is performing well. We are benefitting from our position as a leading supplier of medicines across the region, our deep understanding of local healthcare needs, and our extensive local footprint. This is translating into strong demand across our portfolio, including for our oncology, diabetes and cardiovascular products.

As noted at the half-year, operating costs will be second half weighted as we invest in our pipeline, focusing on first-to-market and first-generic opportunities, and in our commercial activities to support our portfolio.

We are reiterating our guidance for Branded revenue growth in the high-single digits in constant currency, or 6% to 8% on a reported basis, and for reported core operating margin to be around 25%.

Generics

Our Generics business continues to deliver an excellent performance. This reflects our increasingly broad and differentiated portfolio, with a strong contribution from our nasal and inhalation products as well as recent launches. This portfolio breadth is helping to offset the expected increase in competition on certain products.

We remain focused on strengthening our portfolio and pipeline for this business and are on track with R&D investment, which has increased compared with the first half of the year.

We have made strong progress in building a meaningful contract manufacturing (CMO) business and are pleased to announce the signing of a significant new long-term contract with a global pharmaceutical company. Subject to FDA approvals, we expect to begin commercial production for our partner in 2027. Our CMO business is key to our Generics strategy, supporting stronger revenue growth and profitability, while improving the utilisation of our Columbus, Ohio facility.

We continue to expect Generics revenue to grow in the range of 5% to 7% in 2024, and core operating margin to be between 16% and 17%.

Share. Facebook Twitter Pinterest LinkedIn WhatsApp

Related Posts

Business

Yango Group expands ‘Points’ loyalty program to Abu Dhabi with valuable rewards for rides

Business

SBC Summit Malta to Spotlight Next-Gen Tech Driving the Future of Sports Betting

Business

Stitch raises $10 million seed to extend services to emerging markets

Business

Qatar’s PayLater receives strategic investment from LuLu AI

Life

Seven Tides appoints Minor Hotels to manage DUKES The Palm

Life

PUMA MIDDLE EAST INTRODUCES THE MOSTRO SQUAD

Business

CNTXT AI and Beam Partner to Tackle the Gulf’s $5.4 Billion AI Agent Opportunity

Business

Gainz closes pre-seed round to expand SME lending solutions

Leave A Reply Cancel Reply

Stay In Touch
  • Facebook
  • Twitter
Business

Yango Group expands ‘Points’ loyalty program to Abu Dhabi with valuable rewards for rides

Abu Dhabi, UAE, May – Yango Group, the global tech company, has launched the Yango Points program in Abu…

SBC Summit Malta to Spotlight Next-Gen Tech Driving the Future of Sports Betting

Stitch raises $10 million seed to extend services to emerging markets

Qatar’s PayLater receives strategic investment from LuLu AI

Seven Tides appoints Minor Hotels to manage DUKES The Palm

Yango Group expands ‘Points’ loyalty program to Abu Dhabi with valuable rewards for rides

SBC Summit Malta to Spotlight Next-Gen Tech Driving the Future of Sports Betting

Stitch raises $10 million seed to extend services to emerging markets

Qatar’s PayLater receives strategic investment from LuLu AI

Seven Tides appoints Minor Hotels to manage DUKES The Palm

Stay informed with Saudi Journal, your trusted source for comprehensive coverage of news, events, and insights from Saudi Arabia and beyond. Explore diverse perspectives, stay updated, and engage with the latest stories shaping our world. Experience news like never before with Saudi Journal.

Facebook Twitter
Categories
  • Business (291)
  • Life (108)
  • Saudi Arabia (67)
  • Technology (64)
  • Uncategorized (1)
  • World (51)
    • Africa (9)
    • Asia (24)
    • Europe (4)
    • US (3)
Our Picks
Business

MAHY Khoory Automotive to Unveil DONGFENG 007 – The Electric Marvel of the Future – at EVIS Abu Dhabi 2025

Business

Samsung brings its ‘phygital’ space to Dubai Mall

Business

Panasonic Holds Annual Customer Service Conference To Take Customer Experience To The Next Level

© 2025 Saudi Journal.
  • Home
  • Saudi Arabia
  • Business
  • Technology
  • Life
  • English
  • العربية

Type above and press Enter to search. Press Esc to cancel.